ArticleJournal of thoracic disease2025
Use of the PaO
Article in Journal of thoracic disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Percutaneous mechanical thrombectomy using the AcoStream thrombus aspiration system for intermediate-high-risk pulmonary embolism.Journal of thoracic disease · 2026Article
- Refractory Hypoxemia as a Trigger for Systemic Thrombolysis in Intermediate-High-Risk Pulmonary Embolism: A Case Report.Reports (MDPI) · 2025Article
- Machine learning-based risk of pulmonary embolism in stroke patients with lower extremity deep vein thrombosis construction and validation of a prediction model.Frontiers in neurologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Acute pulmonary embolism (APE) is a common pulmonary vascular disease with its incidence rising year by year. Accurate diagnosis and early risk stratification of patients with APE are crucial for treatment follow-up, especially for patients with intermediate-to-high and high-risk. The aim of this study is to explore the value of blood gas parameters, especially arterial partial pressure of oxygen/fraction of inspired oxygen (PaO Methods: A retrospective analysis of demographic data, complications, clinical symptoms, and laboratory data of 227 adult patients with APE treated at Ruijin Hospital, Shanghai Jiao Tong University School of Medicine Ruijin Hospital, from January 2016 to December 2021 was conducted. According to risk stratification, patients were divided into the intermediate-low risk and below group (low-risk group and intermediate-low-risk group), intermediate-high-risk and above group (intermediate-high-risk group and high-risk group), and the correlation between various indicators and risk stratification of APE was analyzed. Multivariate binary logistic regression was used to identify independent influencing factors for intermediate-high-risk and high-risk APE; receiver operating characteristic (ROC) curve analysis was used to evaluate the efficacy of P/F ratio in assessing intermediate-high-risk and high-risk APE. Results: There were significant differences in dyspnea, syncope, and fever among the two groups (P<0.05). There were significant differences in P/F ratio, partial pressure of carbon dioxide (PaCO Conclusions: The P/F ratio has certain evaluative value in risk stratification of APE and can serve as a rapid and convenient method for predicting intermediate-high-risk and high-risk APE.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.